These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2193225)

  • 21. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells.
    Oguchi H; Kikkawa F; Kojima M; Maeda O; Mizuno K; Suganuma N; Kawai M; Tomoda Y
    Anticancer Res; 1994; 14(1A):193-200. PubMed ID: 7909418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells.
    Akman SA; Forrest G; Chu FF; Esworthy RS; Doroshow JH
    Cancer Res; 1990 Mar; 50(5):1397-402. PubMed ID: 2406012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic trioxide in the mechanism of drug resistance reversal in MCF-7/ADM cell line of human breast cancer.
    Wang X; Kong L; Zhao J; Yang P
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):339-43. PubMed ID: 12408759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat-induced bFGF gene expression in the absence of heat shock element correlates with enhanced AP-1 binding activity.
    Erdös G; Lee YJ; Cho JM; Corry PM
    J Cell Physiol; 1995 Aug; 164(2):404-13. PubMed ID: 7622586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
    Benz C; Hollander C; Miller B
    Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.
    Drees M; Zimmermann R; Eisenbrand G
    Cancer Res; 1993 Jul; 53(13):3058-61. PubMed ID: 8391385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ; Ince C; Rosenblum MG; Gallick GE
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of expression and activity of four PKC isozymes in confluent and mechanically stimulated UMR-108 osteoblastic cells.
    Geng WD; Boskovic G; Fultz ME; Li C; Niles RM; Ohno S; Wright GL
    J Cell Physiol; 2001 Nov; 189(2):216-28. PubMed ID: 11598907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in vitro and in vivo study of antitumor effects of gossypol on human SW-13 adrenocortical carcinoma.
    Wu YW; Chik CL; Knazek RA
    Cancer Res; 1989 Jul; 49(14):3754-8. PubMed ID: 2736516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective toxicity of gossypol against epithelial tumors and its detection by magnetic resonance spectroscopy.
    Benz C; Keniry M; Goldberg H
    Contraception; 1988 Mar; 37(3):221-8. PubMed ID: 3370994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
    Swamy MV; Cooma I; Reddy BS; Rao CV
    Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of gossypol on cultured TM3 Leydig and TM4 Sertoli cells: 31P and 23Na NMR study.
    Hansen LL; Jaroszewski JW
    NMR Biomed; 1996 Apr; 9(2):72-8. PubMed ID: 8887371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of gossypol on the cell cycle phases in T-47D human breast cancer cells.
    Thomas M; von Hagen V; Moustafa Y; Montmasson MP; Monet JD
    Anticancer Res; 1991; 11(4):1469-75. PubMed ID: 1746904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An in vitro study of cytotoxic effects of gossypol on human epidermoid larynx carcinoma cell line (HEp-2).
    Konac E; Ekmekci A; Yurtcu E; Ergun MA
    Exp Oncol; 2005 Mar; 27(1):81-3. PubMed ID: 15812364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationships of phenothiazines and related drugs for inhibition of protein kinase C.
    Aftab DT; Ballas LM; Loomis CR; Hait WN
    Mol Pharmacol; 1991 Nov; 40(5):798-805. PubMed ID: 1944244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers.
    Ford JM; Hait WN; Matlin SA; Benz CC
    Cancer Lett; 1991 Jan; 56(1):85-94. PubMed ID: 2004358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiproliferative activity of gossypol and gossypolone on human breast cancer cells.
    Gilbert NE; O'Reilly JE; Chang CJ; Lin YC; Brueggemeier RW
    Life Sci; 1995; 57(1):61-7. PubMed ID: 7596222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of gossypol and 6-aminonicotinamide on tumor cell metabolism: a 31P-magnetic resonance spectroscopic study.
    Keniry MA; Hollander C; Benz CC
    Biochem Biophys Res Commun; 1989 Oct; 164(2):947-53. PubMed ID: 2530981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines.
    Coyle T; Levante S; Shetler M; Winfield J
    J Neurooncol; 1994; 19(1):25-35. PubMed ID: 7815102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereo-specific cytotoxic effects of gossypol enantiomers and gossypolone in tumour cell lines.
    Shelley MD; Hartley L; Fish RG; Groundwater P; Morgan JJ; Mort D; Mason M; Evans A
    Cancer Lett; 1999 Jan; 135(2):171-80. PubMed ID: 10096426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.